Stepping back to step forward: Lessons from the systematic treatment enhancement program for bipolar disorder (STEP-BD)

Journal of Clinical Psychiatry

Volumn 72, Issue 10, 2011, Pages 1429-1431

  Peters, Amy T ^a   Nierenberg, Andrew A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; INOSITOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; PAROXETINE; PLACEBO; RISPERIDONE; VALPROATE SEMISODIUM;

ADD ON THERAPY; AGE; BIPOLAR DEPRESSION; CAUCASIAN; COGNITIVE THERAPY; COMORBIDITY; CONVALESCENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; FAMILY THERAPY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; LIFE SATISFACTION; MANIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SEX RATIO; SOCIAL STATUS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80054933507     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11ac07357     Document Type: Review

References (18)

1. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry. 2003;53(11):1028-1042. doi:10.1016/S06-323(03)0165-3 PubMed (Pubitemid 36645233)
2. Kogan JN, Otto MW, Bauer MS, et al. STEP-BD Investigators. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disord. 2004;6(6):460-469. doi:10.1/j.139-5618.204.0158.x PubMed (Pubitemid 39562413)
3. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006;163(2):217-224. doi:10.176/api.ajp.163.2.217 PubMed (Pubitemid 44480840)
4. Cruz N, Vieta E. Antidepressants in acute bipolar depression: an inconclusive meta-analysis. J Clin Psychiatry. 2011;72(3):415-416, author reply 416. doi:10.408/JCP.10lr0638 PubMed
5. Ghaemi SN, Ostacher MM, El-Mallakh RS, et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010;71(4):372-380. doi:10.408/JCP.08m04909gre PubMed
6. Goldberg JF, Ghaemi SN. Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression. Bipolar Disord. 2005;7(suppl 5):3-12. doi:10.1/j.139-5618.205.0251.x PubMed
7. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722. doi:10.1056/NEJMoa064135 PubMed (Pubitemid 46658703)
8. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry. 2011;72(2):156-167. doi:10.408/JCP.09r05385gre PubMed
9. Chen J, Fang Y, Kemp DE, et al. Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms. Curr Psychiatry Rep. 2010;12(6):512-521. doi:10.107/s1920-010- 0157-z PubMed
10. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547. doi:10.176/api.ajp.161.9.1537 PubMed (Pubitemid 39201448)
11. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;164(9):1348-1355. doi:10.176/api.ajp.207.0512032 PubMed (Pubitemid 47461134)
12. Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210-216. doi:10.176/api.ajp.163.2.210 PubMed (Pubitemid 44480839)
13. van der Loos ML, Mulder PG, Hartong EG, et al. LamLit Study Group. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(2):223-231. doi:10.408/JCP.08m04152 PubMed
14. van der Loos ML, Mulder P, Hartong EG, et al. LamLit Study Group. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord. 2011;13(1):111-117. doi:10.1/j.139-5618.201.087.x PubMed
15. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009;194(1):4-9. doi:10.192/bjp.bp.107.048504 PubMed
16. Calabrese JR, Huffman RF, White RL, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord. 2008;10(2):323-333. doi:10.1/j.139-5618.207.050.x PubMed (Pubitemid 351637697)
17. Miklowitz DJ, Otto MW, Frank E, et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry. 2007;64(4):419-426. doi:10.101/archpsyc.64.4.419 PubMed
18. Miklowitz DJ, Otto MW, Frank E, et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry. 2007;164(9):1340-1347. doi:10.176/api.ajp.207.0702031 (Pubitemid 47461133)